Liver organoids: Updates on disease modeling and biomedical applications

Publication date

2021-08-27

Authors

Caiazza, Carmen
Parisi, Silvia
Caiazzo, MassimilianoORCID 0009-0003-1487-8463ISNI 0000000492840057

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Liver organoids are stem cell-derived 3D structures that are generated by liver differentiation signals in the presence of a supporting extracellular matrix. Liver organoids overcome low complexity grade of bidimensional culture and high costs of in vivo models thus representing a turning point for studying liver disease modeling. Liver organoids can be established from different sources as induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), hepatoblasts and tissue-derived cells. This novel in vitro system represents an innovative tool to deeper understand the physiology and pathological mechanisms affecting the liver. In this review, we discuss the current advances in the field focusing on their application in modeling diseases, regenerative medicine and drug discovery.

Keywords

3D culture, Cholangiocytes, Hepatocyte, Liver disease modeling, Personalized medicine, Stem cells, General Biochemistry,Genetics and Molecular Biology, General Immunology and Microbiology, General Agricultural and Biological Sciences

Citation

Caiazza, C, Parisi, S & Caiazzo, M 2021, 'Liver organoids : Updates on disease modeling and biomedical applications', Biology, vol. 10, no. 9, 835, pp. 1-13. https://doi.org/10.3390/biology10090835